European Archives - Page 934 of 1020 - European Medical Journal

International, Large-Scale, Real-World Clinical Data Confirm the Safety Profile of Rivaroxaban

Rivaroxaban is a direct factor Xa inhibitor and a non-vitamin K antagonist (VKA) novel oral anticoagulant (NOAC) approved for a number of indications.

Real-World Registry Study Confirms Fondaparinux Over Low-Molecular-Weight Heparin for NSTEMI

The pivotal Fifth Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS-5) trial demonstrated that fondaparinux was non-inferior to…

Self-Expanding Coronary Stents: Rationale, Clinical Status, Future Prospects

The mechanical treatment of coronary artery stenoses by placement of balloon-expandable (Bx) coronary stents has become the most widely used invasive…

EMJ Cardiology 3.2 2015

Greetings, and a very warm welcome to European Medical Journal Cardiology, your comprehensive guide to one of the year’s most significant medical events…

EMJ

Low Physical Activity Responsible for 17% of Cardiovascular Deaths in Argentina

Buenos Aires, Argentina, 15 October 2015: Low levels of physical activity are responsible for 17% of cardiovascular deaths in Argentina, reveals research…

EMJ

Progress Made in New(t) Treatment for Osteoarthritis Patients

EXTRAORDINARY progress has been made towards developing effective stem cell treatment for osteoarthritis. Inspired by the ability of animals…

EMJ

Rheumatoid Arthritis Therapy Approved By NICE

BIOLOGIC monotherapy RoActemra has been issued with a positive Final Appraisal Determination by the National Institute for Health and…

EMJ

Dr Jim Duthie, Our #EMJExpert, Answers Your Questions for Blue September

In support of Blue September, an annual campaign designed to raise global awareness for male related cancers, we invited world-renowned urologist Dr Jim…

EMJ

New approaches to molecular cancer therapeutics

At the European Cancer Congress (ECC) 2015, Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research…

EMJ

The Patient Reported Opinions about Clinical Tolerability (PROACT)

At the European Cancer Congress (ECC) 2015, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute UK, London, UK, discusses Patient…